AINDEX
Markets

CONMED Corporation (CNMD)

CNMDNYSEBiotechnology: Electromedical & Electrotherapeutic Apparatus

$50.59

+0.1100 (+0.22%) today

Closed, Nov 13, 4:00 PM ET

+0.22% 1D
Market cap
$1.51bn
P/E
10.7
EPS, last 4 quarters
$4.74
Dividend yield
–
Day range
–
52-week range
$31.44 to $54.80
Average volume
–
Previous close
$50.48

Analysts

5 covering

Underperform0 buy, 5 hold, 0 sell

Targets a year out average $47.25, -6.6% from here

$45.00now $50.59$50.00

Earnings

next estimate $1.27

Next report

Dec 2025

+8.3%

Mar 2026

+8.5%

Jun 2026

+25.4%

Sep 2026

+4.0%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$373.20m$317.05m$343.49m$335.56m
Gross profit$218.28m$183.45m$197.46m$189.15m
Operating income$36.62m$25.41m$36.41m$37.14m
Net income$16.74m$13.83m$23.07m$19.80m

Last four quarters: revenue $1.37bn, margin 5.4%, free cash flow $132.69m

News

8 latest

The company

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, and thoracic surgery.

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
Region
North America
Website
conmed.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.